0

Dexrazoxane

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP24584096
CAS24584-09-6
Structure
MDL NumberMFCD00866449
Molecular Weight268.27
InChI KeyBMKDZUISNHGIBY-ZETCQYMHSA-N
Description≥95% (HPLC)
SolubilityDMSO: >20 mg/mL
Assay≥95% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

Anthracycline Chemotherapy and Cardiotoxicity

John V McGowan, Robin Chung, Angshuman Maulik, Izabela Piotrowska, J Malcolm Walker, Derek M Yellon

Cardiovasc Drugs Ther. 2017 Feb;31(1):63-75.

PMID: 28185035

1

Cardiac Toxicity From Breast Cancer Treatment: Can We Avoid This?

Jesse Caron, Anju Nohria

Curr Oncol Rep. 2018 Jun 6;20(8):61.

PMID: 29876677

1

Chemotherapy-induced Cardiotoxicity in Children

Neha Bansal, Shahnawaz Amdani, Emma R Lipshultz, Steven E Lipshultz

Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):817-832.

PMID: 28679288

1

Extravasation Management: Clinical Update

Lisa Schulmeister

Semin Oncol Nurs. 2011 Feb;27(1):82-90.

PMID: 21255716

1

Risk-benefit of Dexrazoxane for Preventing Anthracycline-Related Cardiotoxicity: Re-Evaluating the European Labeling

Peter Reichardt, Marie-Dominique Tabone, Jaume Mora, Bruce Morland, Robin L Jones

Future Oncol. 2018 Oct;14(25):2663-2676.

PMID: 29747541

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode